Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models

Photo - https://mma.prnewswire.com/media/1213596/Frost_and_Sullivan_Preclinical_Disease_Technology.jpg Photo -https://mma.prnewswire.com/media/1213596/Frost_and_Sullivan_Preclinical_Disease_Technology.jpg For further information on this analysis, please visit:http://frost.ly/48v. "Considerable business opportunities are emerging in the field of precision disease modeling worldwide; one of the main goals of the efforts relies on the support of collaborative research projects...

Preferisci Informazione.News su Google

SANTA CLARA, California, 13/07/2020 (informazione.news - comunicati stampa - editoria e media)

Photo - https://mma.prnewswire.com/media/1213596/Frost_and_Sullivan_Preclinical_Disease_Technology.jpg

For further information on this analysis, please visit: http://frost.ly/48v.

"Considerable business opportunities are emerging in the field of precision disease modeling worldwide; one of the main goals of the efforts relies on the support of collaborative research projects that firmly associate personalized medicine in human subjects with advances in cutting-edge technologies for preclinical research," said Cecilia Van Cauwenberghe, TechVision Industry Principal at Frost & Sullivan. "Going forward, North America and the Asia-Pacific regions are heavily oriented to the use of gene editing and stem cell reprogramming, whereas the adoption of organ-on-chip microfluidic systems and biomimetic sensors have found greater adoption in Europe."

Van Cauwenberghe added: "There is an essential demand for a high level of integration and amalgamation among the most disruptive technologies energizing the preclinical research space. Further, additional research and development is needed to better combine the major strengths of some technologies as well as to generate more reception for additional developments that may also empower these systems."

Innovation in technologies empowering preclinical disease modeling is presenting immense growth opportunities for market participants, including:

Technological Advances Facilitating Research across Preclinical Disease Models is the latest addition to Frost & Sullivan's TechVision research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.